🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

2,153 results for “Ou” Clear

  1. LCAR- F33S cells intravenous infusion

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed/Refractory Multiple Myeloma(MM)

    mab active

    1 trial

  2. Low-fat milk group

    BRIGHT MINDS BIOSCIENCES INC.

    Metabolic Syndrome

    other completed

    1 trial

  3. Lugol's Solution (1.5%)

    Hospital Authority, Hong Kong

    Esophageal Squamous Cell Neoplasm

    small molecule active

    1 trial

  4. Lung Ultrasound (LUS)

    Grace Therapeutics

    Community-acquired Pneumonia

    other active

    1 trial

  5. Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    small molecule completed

    1 trial

  6. Meiji Yogurt Group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    H. Pylori Infection

    other completed

    1 trial

  7. Mupirocin (drug)

    Hospital Authority, Hong Kong

    Biopsy Wound

    small molecule completed

    1 trial

  8. NanoDOX 1% doxycycline monohydrate Hydrogel

    United Therapeutics Europe Ltd

    Dehisced Surgical Wounds

    small molecule terminated

    1 trial

  9. Nut group

    BRIGHT MINDS BIOSCIENCES INC.

    Metabolic Syndrome

    other completed

    1 trial

  10. Olanzapine

    Guangzhou Psychiatric Hospital

    Schizophrenia

    small molecule active

    1 trial

  11. Oral Stimulant Drink

    Cardiff Oncology

    Volatile Organic Compounds

    other active

    1 trial

  12. Oral carbohydrate (Outfast)

    The First People's Hospital of Lianyungang

    Gastrointestinal Surgery

    other completed

    1 trial

  13. Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    Breast Cancers

    small molecule active

    1 trial

  14. Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab

    The First People's Hospital of Lianyungang

    Breast Cancers

    small molecule active

    1 trial

  15. Paclitaxel, gemcitabine or liposomal doxorubicin with or without bevacizumab or biosimilar

    The University of Hong Kong

    Recurrent Ovarian Carcinoma

    small molecule active

    1 trial

  16. Peak value anti-Xa

    The First People's Hospital of Lianyungang

    Venous Thromboembolism

    other active

    1 trial

  17. Percutaneous Transluminal Angioplasty (PTA)

    Blackmores Limited

    Peripheral Artery Disease

    other active

    1 trial

  18. Percutaneous Transluminal Angioplasty (PTA) MagicTouch Sirolimus Coated PTA Balloon Catheter

    Blackmores Limited

    Peripheral Artery Disease

    other active

    1 trial

  19. Percutaneous transhepatic biliary stenting with conventional linear ^125^I seeds strand

    The First People's Hospital of Lianyungang

    Malignant Obstructive Jaundice

    other completed

    1 trial

  20. Postoperative radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oral Tongue Squamous Cell Carcinoma

    other active

    1 trial

  21. Prospan cough Syrup

    Hong Kong Baptist University

    Cough Severity

    small molecule completed

    1 trial

  22. REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]

    Hospital Authority, Hong Kong

    Hemodynamic Instability

    small molecule completed

    1 trial

  23. Rituximab, Methotrexate, and Thiotepa (R-MT) Induction Followed by Etoposide and Cytarabine (EA) Consolidation

    The First People's Hospital of Lianyungang

    Primary Central Nervous System Lymphoma (PCNSL)

    small molecule active

    1 trial

  24. Routine IOP-lowering medications

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    Open Angle Glaucoma

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources